H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 293,330. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Durham clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Durham storefront.
Orthobiologic Treatments for Your Practice in Durham, NC for clinics & physicians. Premium orthobiologic t… Compliance support & pricing — contact Hawk Medical.
Durham is a city of 250k–500k (293,330 Census). CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Adult arthritis here is 20.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.2% of adults in Durham have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Adult obesity in Durham is 36.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JM / Palmetto GBA, sibling states SC, VA, WV. N.C. Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JM articles mapped. 10.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 36.8%; arthritis is 20.6%. That is place-level BRFSS modeling, not a clinic census and not a Durham trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in North Carolina.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including North Carolina.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Durham tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Durham, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Durham is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Durham — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Durham. Useful for joint-program math; still needs a diagnosis and privileging.
No Durham storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.